Essex Bio-Technology Included in "Forbes Asia’s Best Under A Billion 2022" – QNT Press Release

HONG KONG, Aug 16, 2022 – (ACN Newswire) – Essex Bio-Technology Ltd (“EssexBio” or the “Group”, Stock Code: 1061.HK) is pleased and honoured to announce that it is included in “Forbes Asia’s 200 Best Under A Billion 2022” – for the Group’s outstanding long-term sustainable development across a variety of metrics.

(Source: forbes.com)

Only 200 companies were selected out of 20,000 publicly traded companies (with annual sales of between $10 million and $1 billion) in the Asia-Pacific region. The 200 companies were carefully picked based on Forbes’ List Methodology ^ of quantitative criteria and qualitative screens.

EssexBio would like to extend its gratitude to all stakeholders for their contributions. For sustainable long-term growth and enhancing shareholder value, EssexBio will continue to strive for excellence by embracing innovation to develop first-in-class …